Back
Corcept Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
CORT
Corcept Therapeutics
Last Price:
$71.00
Seasonality Move:
7.28%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and CORT is experiencing slight buying pressure.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.63 | Buy |
| 20-day SMA: | 72.11 | Buy |
| 50-day SMA: | 72.52 | Buy |
| 200-day SMA: | 62.04 | Buy |
| 8-day EMA: | 72.08 | Buy |
| 20-day EMA: | 71.91 | Buy |
| 50-day EMA: | 69.31 | Buy |
| 200-day EMA: | 40.15 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 53.11 | Buy |
| Chaikin Money Flow: | 5299 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.96 - 73.84) | Buy |
| Bollinger Bands (100): | (60.53 - 77.73) | Buy |
Corcept Therapeutics Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 73.10 while CORT 8-day simple moving average is 71.63, which is a Buy signal.
-
The stock price of CORT is 73.10 while Corcept Therapeutics 20-day SMA is 72.11, which makes it a Buy.
-
Corcept Therapeutics 50-day simple moving average is 72.52 while CORT share price is 73.10, making it a Buy technically.
-
CORT stock price is 73.10 and Corcept Therapeutics 200-day simple moving average is 62.04, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
61
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $73.10. The Score for CORT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
7.8B
Price in USD:
73.10
Share Volume:
726K
Corcept Therapeutics 52-Week Range
52-Week High:
117.33
52-Week Low:
32.33
Buy
61
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 73.10 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 73.10 while CORT 8-day exponential moving average is 72.08, which is a Buy signal.
-
The stock price of CORT is 73.10 while Corcept Therapeutics 20-day EMA is 71.91, which makes it a Buy.
-
Corcept Therapeutics 50-day exponential moving average is 69.31 while CORT share price is 73.10, making it a Buy technically.
-
CORT stock price is 73.10 and Corcept Therapeutics 200-day simple moving average is 40.15, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.03 per share, and an increase next year of $1.28 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting Corcept Therapeutics is a Buy
-
Corcept Therapeutics Relative Strength Index (RSI) is 53.11, which suggest Corcept Therapeutics is overbought
-
The Bollinger Bands (25) for Corcept Therapeutics is (69.96 - 73.84), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (60.53 - 77.73), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.